CCNB1 and prostate cancer: Studies have also confirmed that the treatment of human prostate cancer cells with 2-methoxyestradiol or docetaxel causes cyclin B1 protein accumulation and an increase in cyclin B1 kinase activity, followed by induction of apoptotic cell death.